Rescription

Rescription is a next-generation full PBM solution that leverages health system partnerships to deliver pharmacy benefits at net costs 20-40% lower than any alternative, without the need to limit patient drug choice. It replaces the traditional PBM with a new delivery model that includes 100% of all prescription drugs at the lowest price. The company fully supports the change from a traditional PBM to its model, including claim servicing, administrative, and retail network infrastructure. Leveraging pharmacy, specialists, and 340B purchasing capabilities, Rescription creates a preferred network for patients and their families. All drugs are passed through at their sourced price, and Rescription simply charges a subscription-based fee per member, meaning that Rescription's only financial incentive is to save its clients and partners money on their prescription drug costs. Based in the United States, Rescription caters to the industries of Data Analytics, Health Care, Information Technology, and Pharmaceutical. As of 2021, there is no publicly available information about the company's last investment or its investors. Health systems interested in prescription drug savings opportunities can learn more at www.rescription.com.